BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7433215)

  • 1. [Effect of persantin on selected platelet functions in myocardial infarct].
    Markiewicz M; Kowalewski J; Florkiewicz H; Pluta A; Koziara Z; Szponar M; Dmosyńska A
    Pol Tyg Lek; 1980 Sep; 35(35):1343-5. PubMed ID: 7433215
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rsearch into the inhibitory effect of dipyridamole on the adhesion and clumping of blood platelets "in vitro" and "in vivo"].
    Griguer P; Brochier M; Raynaud R
    Ann Cardiol Angeiol (Paris); 1975; 24(1 SUPPL):1-36. PubMed ID: 1096747
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.
    Jhawar BK; Trivedi HH; Bhargava RK; Misra NP
    J Assoc Physicians India; 1978 Sep; 26(9):805-9. PubMed ID: 370078
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of dipyridamole on coagulation status in stenocardia].
    Ficović P; Gjurić Z; Grgić Z
    Bilt Hematol Transfuz; 1978; 6(2):49-55. PubMed ID: 754694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Platelet hyperaggregation premonitory of myocardial infarct? A clinical case report].
    Taccola A; Cipolli PL; Bossi MC
    Minerva Med; 1981 Jan; 72(2):101-5. PubMed ID: 7465105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative statistical study of the treatment of myocardial infarct with anticoagulants and anti-aggregants].
    Melloni GF; Lureti GF; Minoja GM; Melloni CF; Scarlatti GF; Facchetti M; Fassini G
    Boll Soc Ital Cardiol; 1977; 22(7):1017-26. PubMed ID: 87208
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-platelet-aggregating action of dipyridamole administered by slow intravenous infusion].
    Francini D; Abbate R
    Clin Ter; 1980 Mar; 92(5):477-89. PubMed ID: 7449325
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of nitroglycerin on platelet aggregation in acute myocardial infarct].
    Shilov AM; Orlov LL; Gariaev LA; Amunts MG; Roĭtberg GE
    Sov Med; 1984; (9):3-7. PubMed ID: 6438807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Processes of oxidation-reduction, adhesiveness and aggregation of the thrombocytes in myocardial infarct].
    Orlova NP; Lokhvitskaia NL; Volodin EE
    Sov Med; 1977 Sep; (9):18-21. PubMed ID: 929293
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and electrocardiographical observations on the evolution of myocardial infarct treated with a derivative of pyrimido-pyrimidine (Persantin) in intravenous infusion].
    Martinetti L; Balzano I
    Minerva Med; 1966 Aug; 57(63):2699-710. PubMed ID: 5911867
    [No Abstract]   [Full Text] [Related]  

  • 12. [Early changes of platelet aggregation and course of acute myocardial infarct (AMI)].
    Porro F; Delù A; Mangiarotti R; Martinotti R; Sardella F; Fanelli M
    Boll Soc Ital Cardiol; 1981; 26(10):975-81. PubMed ID: 7349180
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
    Caruzzo C; Belli R; Biasci R; Gaschino G; Bruna C
    Minerva Cardioangiol; 1979 Jun; 27(6):367-72. PubMed ID: 38413
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of platelet activity in patients with prosthetic heart valves.
    Bran M; Capel P; Messin R
    Rev Med Brux; 1980 Feb; 1(2):71-5. PubMed ID: 7403713
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of administration of hydrocortisone and dipyridamole (persantin) on plasma levels of prostaglandin E1 and F2 alpha in patients with myocardial infarction].
    Miturzyńska-Stryjecka H
    Wiad Lek; 1987 Nov; 40(21):1441-6. PubMed ID: 3482754
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood platelet function before and after dipyridamole in patients on chronic hemodialysis].
    Twardowski Z; Janicka L; Dmoszyńska A; Gutka A; Pluta A; Kowalewski J
    Pol Arch Med Wewn; 1980 Apr; 63(4):383-91. PubMed ID: 7413468
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observations on the treatment of myocardial infarct with 2-6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d)-pyrimidine (Persantin) in slow venous perfusion].
    Marangoni R; Brera V; Ferrari A
    Minerva Cardioangiol; 1966 Jun; 14(6):373-9. PubMed ID: 5917541
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiaggregant effect of slow-release dipyridamole in acute myocardial infarct].
    Scabbia E; Bellocci F; Montenero AS; Albanese S; Coppola E; Cudillo L
    Minerva Cardioangiol; 1988; 36(7-8):347-50. PubMed ID: 2974931
    [No Abstract]   [Full Text] [Related]  

  • 19. [Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
    Avellone G; Mandalà V; Novo S; Pinto A; Riolo FP; Davì G; Raneli G
    Boll Soc Ital Cardiol; 1981; 26(8):697-712. PubMed ID: 6289854
    [No Abstract]   [Full Text] [Related]  

  • 20. [Processes of oxidation-reduction and adhesiveness and agreggation of thrombocytes in complications of acute myocardial infarct].
    Orlova NP; Lokhvitskaia NL; Volodin EE
    Ter Arkh; 1978; 50(4):12-6. PubMed ID: 663831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.